Enfortumab vedotina perioperatoria más pembrolizumab frente a quimioterapia neoadyuvante para el cáncer de vejiga con invasión muscular elegible para cisplatino
The purpose of this study is to assess the antitumor efficacy and safety of perioperative enfortumab vedotin (EV) plus pembrolizumab and radical cystectomy (RC) + pelvic lymph node dissection (PLND) compared